Assyro AI

Orange Book product · Generic (ANDA)

MITOXANTRONE HYDROCHLORIDE

MITOXANTRONE HYDROCHLORIDE

Generic (ANDA)ANDA 078606DISCN FRESENIUS KABI ONCOL

At a glance

May 14, 2008

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 14, 2008

    18 yr 4 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

MITOXANTRONE HYDROCHLORIDE

Strength

EQ 20MG BASE/10ML (EQ 2MG BASE/ML)

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 078606

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MITOXANTRONE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.